Torben Straight Nissen took over the reins of Repertoire Immune Medicines at the tail end of 2022, at a time when the ...
Around the world, 100 companies have debuted weight-loss medications, which have become a multimillion-dollar business. Novo ...
Eagle-eyed watchers of Deloitte’s annual reports on Big Pharma will have noticed a depressing trend—ever-increasing costs for ...
The government’s response to the COVID-19 pandemic opened the people’s eyes to the relentless power of pharmaceutical ...
Bristol-Myers Squibb’s market capitalization has dropped so much over the past year that it is now arguably no longer part of ...
The upshot: Smaller weight-loss drug companies are in the buyout sights of the big players. This trend ramped up in 2023, ...
A group of prominent pharma companies unveiled their respective earnings Thursday morning, with some soaring and others ...
When longtime Evanston resident Martha Rosenberg, who served as the RoundTable’s editorial cartoonist for two decades, ...
Dorchester Alcohol and Drug Commission celebrates 50 years of fighting substance addiction with an opioid strategic plan and ...
Big pharma continues to seek innovation in China despite rising geopolitical tension, speakers said at the Asia Bio Partnering Forum in Singapore April 24.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback